Opinion
18 Civ. 4361 (AKH)
03-16-2022
IN RE NOVARTIS AND PAR ANTITRUST LITIGATION
ORDER
ALVIN K. HELLERSTEIN, U.S.D.J.
On December 23, 2020 Defendant Novartis filed a motion to compel non-party OptumRX to produce certain documents. ECF No. 314. That motion is marked as open, though discovery has now closed. No. later than March 23, 2022, Defendant Novartis shall advise the Court, via letter filed on ECF, as to the status of its motion, and if the motion requires resolution by the Court.
Additionally, in connection with that motion, OptumRX filed a letter motion to seal portions of its opposition. ECF No. 330. That request is granted, and the Clerk shall terminate ECF No. 330.
SO ORDERED.